Dr. Maxime Depasse SRL
Dr. Maxime Depasse reported total assets of 8,376 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of Dr. Maxime Depasse shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Maxime Depasse's annual accounts
| 2025 | |
|---|---|
| Net result | −5,466 € |
| Equity | −2,466 € |
| Cash | 5,100 € |
| EBITDA | −5,466 € |
| Total assets | 8,376 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
Dr. Maxime Depasse's financial analysis
- Solvency-29.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Maxime Depasse
Dr. Maxime Depasse's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1028.090.330
- VAT number
- BE1028090330
- Peppol
- Registered · 0208:1028090330 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Sep 2025
- Registered office
- 2600 Antwerp
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Maxime Depasse (SRL) has been based in Antwerp since 2025, active in: medical specialists activities. For 2025, it reports a net loss of 5,466 € and equity of −2,466 €; its revenue is not published. Its solvency stands at -29.4%, below the median of its sector (72.2%).
Companies similar to Dr. Maxime Depasse
Companies in the same business, of comparable size and area, outside its group.
- Narcis Buying and selling of own real estate Antwerp · balance sheet 8,377 €
- Rebuildx Manufacture of doors and windows of plastic Edegem · balance sheet 8,390 €
- P77 Computer programming activities Ghent · balance sheet 8,391 €
- Recuplan Manufacture of other products of wood and articles of cork, straw and plaiting materials Mechelen · balance sheet 8,402 €
- Kaleido Pre-press and pre-media services Schaerbeek · balance sheet 8,349 €
- Cemacor Houffalize · balance sheet 8,373 €
Frequently asked questions about Dr. Maxime Depasse
What is the revenue of Dr. Maxime Depasse?
Dr. Maxime Depasse files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Maxime Depasse?
In Belgium, the VAT number is the company number prefixed with BE: BE1028090330 for Dr. Maxime Depasse, if the company is VAT-registered. Its company number (CBE) is 1028.090.330.
Where is the registered office of Dr. Maxime Depasse?
According to the CBE register, the registered office of Dr. Maxime Depasse is in 2600 Antwerp.
What is the equity of Dr. Maxime Depasse?
At the close of the 2025 financial year, the equity of Dr. Maxime Depasse amounts to -2,466 €, a solvency of -29.4% of total assets.
Who manages Dr. Maxime Depasse?
The register lists 1 active mandates at Dr. Maxime Depasse. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Maxime Depasse
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →